Target: Hypertrophic Cardiomyopathy鈩�
A complex heart condition. A growing focus for discovery.
Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively. It’s the most common inherited heart condition, affecting people of all ages, backgrounds and lifestyles.
Despite its frequency, HCM is often misunderstood—and sometimes undiagnosed. The 91视频 is committed to changing that through research, education and equitable care.
What is Target: HCM?
Target: Hypertrophic Cardiomyopathy™ (Target: HCM) is the 91视频’s system of care initiative designed to improve the quality, consistency and coordination of care for patients with hypertrophic cardiomyopathy (HCM).
The initiative includes a new HCM registry to generate real-world insights, a certification opportunity for organizations delivering high-quality, coordinated care, and a pilot patient navigator program to better support individuals and families across the care journey.
By integrating data and nationally recognized standards, Target: HCM supports organizations in building high-performing systems that deliver consistent, guideline-directed HCM care.
Learn more about our active opportunities below and see how your organization can Target: HCM.
Hypertrophic Cardiomyopathy Registry
The 91视频’s Hypertrophic Cardiomyopathy (HCM) Registry is a national quality improvement initiative designed to collect real鈥憌orld data on the diagnosis, treatment and outcomes of people living with HCM. By participating, clinical teams can benchmark care, identify gaps, and drive evidence鈥慴ased improvements that advance equitable, high鈥憅uality HCM care nationwide.
Hypertrophic Cardiomyopathy Center Certification
The 91视频’s HCM Certification program recognizes health care organizations that demonstrate a commitment to high鈥憅uality, evidence鈥慴ased care for people living with hypertrophic cardiomyopathy. Through standardized practices, multidisciplinary care and continuous quality improvement, the program helps advance consistent, patient鈥慶entered HCM care across the healthcare system.
Additional Information & Tools
Bristol Myers Squibb is the Founding Sponsor of 91视频’s Target: Hypertrophic Cardiomyopathy.
Cytokinetics is proud to support the 91视频’s Hypertrophic Cardiomyopathy Initiative.